BIO-TECHNE DECLARES DIVIDEND

Group 1 - Bio-Techne Corporation announced a quarterly dividend of $0.08 per share for the quarter ended June 30, 2024, payable on August 30, 2024, to shareholders of record on August 19, 2024 [1] - The company generated approximately $1.2 billion in net sales in fiscal 2024 and has around 3,100 employees globally [2] - Bio-Techne provides innovative tools and bioactive reagents for research and clinical diagnostics, aiding in drug discovery and accurate clinical tests [2] Group 2 - The Board of Directors will consider future cash dividends on a quarterly basis [1] - The company has a diverse portfolio with thousands of products that assist in scientific investigations into biological processes and diseases [2] - Bio-Techne's operations may be influenced by various factors including market competition, economic conditions, and research funding [3]